Lv11
42 积分 2026-05-16 加入
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
2天前
已完结
Evolocumab in Patients without a Previous Myocardial Infarction or Stroke
2天前
已关闭
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study
14天前
已完结
Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis
29天前
已完结
Impact of conventional lipid‐lowering therapy on circulating levels of proprotein convertase subtilisin/kexin type 9: A systematic review and meta‐analysis of randomised controlled trials
6个月前
已完结